Division of Internal Medicine.
Division of Pulmonary Medicine, University Hospital Zurich, Zurich, Switzerland.
Curr Opin Organ Transplant. 2019 Jun;24(3):324-328. doi: 10.1097/MOT.0000000000000630.
Lung transplantation has become an accepted therapy in infants, children, and adolescents suffering from end-stage lung diseases, an impaired quality of life and reduced life expectancy. The aim of this review is to highlight specific aspects of pediatric lung transplantation and to give an update on recent findings.
Currently, over 100 lung transplant procedures are performed in children annually worldwide. Long-term success is limited by availability of donor organs and waitlist mortality pretransplant, and an increased infection risk because of immunosuppression, and most importantly late complications, such as chronic lung allograft dysfunction, medication nonadherence, and transition intricacies.
Specific aspects of pediatric lung transplantation will be reviewed and an update on most recent developments in the management of pediatric lung transplant recipients given.
肺移植已成为治疗终末期肺部疾病、生活质量受损和预期寿命缩短的婴幼儿和青少年的一种可接受的疗法。本文旨在强调儿科肺移植的具体方面,并更新最近的发现。
目前,全球每年有 100 多例肺移植手术在儿童中进行。长期成功受到供体器官的可用性和移植前等待名单死亡率的限制,以及免疫抑制引起的感染风险增加,最重要的是晚期并发症,如慢性肺移植物功能障碍、药物不依从和过渡期的复杂性。
本文将对儿科肺移植的具体方面进行综述,并介绍儿科肺移植受者管理方面的最新进展。